Diagnostics

NewAmsterdam Announces Acceptance of Marketing Authorization Applications for Review by European Medicine Agency for Obicetrapib

-- Filings both for the obicetrapib monotherapy and obicetrapib plus ezetimibe fixed-dose combination submitted to EMA by our partner, Menarini,...

RIVANNA secures $800,000 Virginia Catalyst Grant alongside matching funds to advance AI-enabled ultrasound platform for neuraxial anesthesia

CHARLOTTESVILLE, Va., Aug. 14, 2025 /PRNewswire/ -- RIVANNA®, developers of world-first imaging-based medical technologies, was recently awarded grant funding valued...

AvodahMed and Pulse4Pulse Partner to Enhance Preventative Care with AI-Driven Screening Solutions

Collaboration enhances patient outcomes, improves provider efficiency, and streamlines workflow diagnostics WESTLAKE, Texas and MIDDLEBURY, Conn., Aug. 14, 2025 /PRNewswire/ -- AvodahMed, a leader in AI-powered clinical documentation, and Pulse4Pulse (P4P), a pioneer...

Biotricity Reinforces Growth Trajectory, Kicking Off Fiscal 2026 with Strong First Quarter Results Featuring Revenue Growth, Positive EBITDA and Improved Margins

REDWOOD CITY, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company”), an innovative Technology-as-a-Service (TaaS)...

Analytics For Life Completes Clinical Study of Non-Invasive Point-of-Care Test for Elevated Pulmonary Capillary Wedge Pressure (PCWP) Using Machine Learning

Study achieves primary sensitivity endpoint, advancing diagnostics for heart failure with preserved ejection fraction (HFpEF) and pulmonary hypertension (PH)Results build...

Plus Therapeutics Presents Positive CNSide CSF Assay Platform Results at the 2025 SNO/ASCO CNS Metastases Conference

CNSide® can quantify leptomeningeal metastases (LM) over time and monitor changes in the expression of multiple targetable mutations CNSide® may...

error: Content is protected !!